( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals
World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

ISSN 2457-0400

Impact Factor  :  5.464

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • WJAHR New Impact Factor

    Its our Pleasure to Inform you that WJAHR Impact Factor has been increased from  4.897 to 5.464 due to high quality Publication at International Level

  • .



    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019


    MAY 2023 Issue has been successfully launched on 1 MAY 2023.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR May 2023 Issue has been Published, Kindly check it on

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here




*Nour Alhaji, Ahmad Yousef, Sahar Hasan


Background: The termination of pregnancy by abortion in the first trimester of pregnancy and after the patient's suffering with the threat of abortion poses a social, psychological and economic dilemma, with the absence of a specific factor of high sensitivity and specificity useful in predicting when the threat of abortion occurs. Aim: Determination of the true value of the MPV titer as a cheap and available prognostic factor for predicting pregnancy outcome in patients with threatened abortion in the early stage of pregnancy. Materials and METHODS: This study is a prospective case-control study. The study included pregnant women attending the Department of Obstetrics and Gynecology Tishreen University Hospital TUH in Lattakia. In the period from the beginning of March 2022 until the end of February 2023? for those who have met the criteria for admission. The women in the study sample were divided into two groups as follows: 1. The first group included 45 women - The group of cases: it is a group of women who have the threatened abortion and who fulfill the conditions of admission and exclusion. 2. The second group included 35 women - The control group: a group of pregnant women with a normal pregnancy who went to hospital for the purpose of routine monitoring. Results: There were no statistically significant differences between the two groups in terms of age of the pregnant woman, gestational age, number of pregnancies, and number of abortions. The average number of platelets in the abortion group was higher than that of the control group, and it was higher in the event of a abortion compared to when it did not occur, but by statistical analysis the differences were not significant, which is consistent with slight changes in the number of platelets during the development of pregnancy. MPV and PDW were significantly higher (P<0.05) in the abortion threat group compared to normal pregnancy, and higher in women who developed a abortion compared to those who did not, The mean values of MPV in the abortion group were 10.4 ± 1.6 and in the normal pregnancy group 8.02 ± 0.8 with p-value = 0.001, while the mean values of PDW were 15.33 ± 1.1 in the abortion group and 13.6 ± 1.2 in the normal pregnancy group with p-value = 0.02. Conclusions: The rise in mean platelet volume can be used as a predictor of the risk of abortion. The value 10.2 achieves the best fit among the predictive values and is suggested as a cut-off value for predicting abortion.

[Full Text Article]